Percutaneous or surgical revascularization for left main stem disease: NOBLE ideas, but do they EXCEL?

2019 ◽  
Vol 17 (5) ◽  
pp. 361-368
Author(s):  
George Kassimis ◽  
Tushar Raina ◽  
Nestoras Kontogiannis ◽  
George Krasopoulos ◽  
Julian Gunn
1981 ◽  
Vol 47 ◽  
pp. 423
Author(s):  
John E. Deanfield ◽  
Kim M. Fox ◽  
Anne Jonathan ◽  
Andrew P. Selwyn

2012 ◽  
Vol 144 (5) ◽  
pp. 1273-1274
Author(s):  
Jamil Hajj-Chahine ◽  
Christophe Jayle ◽  
Pierre Corbi

2021 ◽  
Vol 15 (6) ◽  
pp. 1456-1458
Author(s):  
F. Ali ◽  
Q. A. Saboor ◽  
T. Mahmud ◽  
F. Ali ◽  
H. Bashir ◽  
...  

Aim: To determine the association of left main stem disease with diabetes and hypertension in STEMI patients underwent coronary angiography Methodology: This study was conducted at Department of Cardiology, Sheikh Zayed Hospital, Lahore during January to June 2019 where 220 patients with age ranging from 40-70 years whether male or female, presenting with STEMI, In Exposed Group: Patients presenting with STEMI having diabetes and hypertension and Unexposed Group: Patients of STEMI without diabetes and hypertension. We excluded all cases with recurrent MI or undergoing recurrent PCI (on medical record), valvular heart disease, and cardiogenic shock. Then two groups were formed i.e. exposed group with diabetes and hypertension and unexposed group without diabetes and hypertension. All patients underwent angiography by a senior consultant cardiologist with assistance of researcher. On angiography, presence of LMS disease was ≥50% occlusion (stenosis) in LMS artery. Angiography reports were assessed and LMS disease was noted labeled. Patients with LMS disease was managed as per hospital protocol. Results: In this study risk of LMS was higher among exposed group as compared to un exposed group. i.e. exposed: 19.1% & Unexposed: 5.5%, RR=3.50 The risk of LMS among exposed group was higher for patients in the age group 51-60 years (RR=8.00), for male patients (RR=5.76) risk for LMS was higher as compared to female patients in exposed group, patients with normal BMI (RR:2.20) and patients with shorter duration of STEMI in exposed group had higher risk for LMS (1-4 weeks: RR=7.54). Conclusion: Results of this study showed that hypertensive and diabetic patients presenting with STEMI had higher risk for LMS disease. Keywords: Left main stem, Diabetes, Hypertension, Coronary, Angiography


Open Heart ◽  
2018 ◽  
Vol 5 (2) ◽  
pp. e000804
Author(s):  
J J Coughlan ◽  
Nial Blake ◽  
Napohn Chongprasertpon ◽  
Munir Ibrahim ◽  
Samer Arnous ◽  
...  

PurposeIn this study, we sought to prospectively analyse the management and long term outcomes associated with revascularisation of left main stem disease via percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in our centre.MethodsThis prospective study enrolled all patients with unprotected left main stem disease undergoing revascularisation from January 2013 to June 2014. Baseline characteristics, hospital presentation and hospital stay length were collected. Patients were followed up at 1, 2 and 3 years. Primary outcomes of Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) were defined as death, Q wave myocardial infarction, stroke, repeat revascularisation and readmission within 30 days.Results56 patients with significant left main stem coronary artery disease were identified from the clinical registry. 27 patients underwent PCI (median age 67.7) and 29 CABG (median age 68.6). PCI patients had a higher surgical risk as measured by mean euroSCORE (4.95±5.8 vs 3.11±3.85). At 3 years, total MACCE occurred in 29.6% of the PCI cohort and 27.5% of the CABG cohort. Death occurred in three patients in the PCI group within the first 6 months. Death occurred in one patient in the CABG group over 2 years postprocedure. Two patients in the CABG cohort presented with Transient Ischemic Attacks (TIAs) at 2-year follow-up. At 3 years, revascularisation occurred in three patients in the PCI cohort. There were no revascularisation events in the CABG cohort.ConclusionsPCI with modern drug eluting stents is a reasonable treatment option for unprotected left main stem disease in a non surgical centre.


2011 ◽  
Vol 13 (S1) ◽  
Author(s):  
Arshad Zaman ◽  
David L Buckley ◽  
Steven Sourbron ◽  
Neil Maredia ◽  
John F Younger ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document